Loading…

End-systolic measures of regional ventricular performance

Dimension change measures of regional ventricular function, such as absolute or percent wall thickening (delta T or % delta T) or segmental shortening (delta L or % delta L), are highly load dependent. In 16 anesthetized mongrel dogs we assessed use of the end-systolic pressure-thickness and end-sys...

Full description

Saved in:
Bibliographic Details
Published in:Circulation (New York, N.Y.) N.Y.), 1986-05, Vol.73 (5), p.938-950
Main Authors: AVERSANO, T, MAUGHAN, W. L, HUNTER, W. C, KASS, D, BECKER, L. C
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c468t-fd06e8cfb23c5049cfe341fc83ef886c2607a59a3cd6a8376e6bac2138efa2b23
cites
container_end_page 950
container_issue 5
container_start_page 938
container_title Circulation (New York, N.Y.)
container_volume 73
creator AVERSANO, T
MAUGHAN, W. L
HUNTER, W. C
KASS, D
BECKER, L. C
description Dimension change measures of regional ventricular function, such as absolute or percent wall thickening (delta T or % delta T) or segmental shortening (delta L or % delta L), are highly load dependent. In 16 anesthetized mongrel dogs we assessed use of the end-systolic pressure-thickness and end-systolic pressure-length relationships (ESPTR, ESPLR) as more load-independent measures of regional function. We found that the ESPTR and ESPLR could be measured without detectable baroreceptor-mediated reflex changes in cardiac contractile state. Systemic administration of dobutamine shifted the ESPTR to the right and the ESPLR to the left of control, mainly due to a change in the slope (Ees) of the relationships. Both delta T, % delta T and delta L, % delta L failed to detect the positive inotropic effect of dobutamine because of an associated reduction in preload. With systemic administration of propranolol, ESPTR, ESPLR, delta T, % delta T, and delta L, % delta L detected the negative inotropic effect. Thus systemic propranolol shifted the ESPTR to the left and the ESPLR to the right of control, mainly due to a change in Ees. Regional administration of dobutamine shifted the ESPTR and the ESPLR in the direction of positive contractility in the region receiving the drug, whereas simple dimension change measures of regional function failed to detect the inotropic effect because preload fell and the timing of regional end-systole was altered. With regional propranolol both the ESPTR, ESPLR and simple dimension change measures detected the negative inotropic effect. Thus the ESPTR, ESPLR is a reliable measure of regional ventricular function and may be better than simple dimension change measures of regional function, particularly when loading conditions or the timing of regional systole is altered by an intervention.
doi_str_mv 10.1161/01.cir.73.5.938
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76802390</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76802390</sourcerecordid><originalsourceid>FETCH-LOGICAL-c468t-fd06e8cfb23c5049cfe341fc83ef886c2607a59a3cd6a8376e6bac2138efa2b23</originalsourceid><addsrcrecordid>eNo9kM1LAzEQxYMotVbPnoQ9iLfdJpndbHKUUrVQEETPIc1OZGU_arIr9L9vpEtPwzC_95j3CLlnNGNMsCVlma19VkJWZArkBZmzgudpXoC6JHNKqUpL4Pya3ITwE1cBZTEjMxBKclBzotZdlYZDGPqmtkmLJoweQ9K7xON33XemSf6wG3xtx8b4ZI_e9b41ncVbcuVME_Bumgvy9bL-XL2l2_fXzep5m9pcyCF1FRUordtxsAXNlXUIOXNWAjopheWClqZQBmwljIRSoNgZyxlIdIZH1YI8nXz3vv8dMQy6rYPFpjEd9mPQpZA0RqERXJ5A6_sQPDq993Vr_EEzqv_L0pTp1eZDl6ALHcuKiofJety1WJ35qZ14f5zuJljTOB9z1-GMSaFYfB-OZpJyqg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76802390</pqid></control><display><type>article</type><title>End-systolic measures of regional ventricular performance</title><source>EZB Electronic Journals Library</source><creator>AVERSANO, T ; MAUGHAN, W. L ; HUNTER, W. C ; KASS, D ; BECKER, L. C</creator><creatorcontrib>AVERSANO, T ; MAUGHAN, W. L ; HUNTER, W. C ; KASS, D ; BECKER, L. C</creatorcontrib><description>Dimension change measures of regional ventricular function, such as absolute or percent wall thickening (delta T or % delta T) or segmental shortening (delta L or % delta L), are highly load dependent. In 16 anesthetized mongrel dogs we assessed use of the end-systolic pressure-thickness and end-systolic pressure-length relationships (ESPTR, ESPLR) as more load-independent measures of regional function. We found that the ESPTR and ESPLR could be measured without detectable baroreceptor-mediated reflex changes in cardiac contractile state. Systemic administration of dobutamine shifted the ESPTR to the right and the ESPLR to the left of control, mainly due to a change in the slope (Ees) of the relationships. Both delta T, % delta T and delta L, % delta L failed to detect the positive inotropic effect of dobutamine because of an associated reduction in preload. With systemic administration of propranolol, ESPTR, ESPLR, delta T, % delta T, and delta L, % delta L detected the negative inotropic effect. Thus systemic propranolol shifted the ESPTR to the left and the ESPLR to the right of control, mainly due to a change in Ees. Regional administration of dobutamine shifted the ESPTR and the ESPLR in the direction of positive contractility in the region receiving the drug, whereas simple dimension change measures of regional function failed to detect the inotropic effect because preload fell and the timing of regional end-systole was altered. With regional propranolol both the ESPTR, ESPLR and simple dimension change measures detected the negative inotropic effect. Thus the ESPTR, ESPLR is a reliable measure of regional ventricular function and may be better than simple dimension change measures of regional function, particularly when loading conditions or the timing of regional systole is altered by an intervention.</description><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/01.cir.73.5.938</identifier><identifier>PMID: 3698239</identifier><identifier>CODEN: CIRCAZ</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Animals ; Biological and medical sciences ; Blood Pressure - drug effects ; Cardiovascular system ; Dobutamine - pharmacology ; Dogs ; Female ; Heart - anatomy &amp; histology ; Heart - physiology ; Hemodynamics - drug effects ; Investigative techniques of hemodynamics ; Investigative techniques, diagnostic techniques (general aspects) ; Male ; Medical sciences ; Myocardial Contraction - drug effects ; Pressoreceptors - drug effects ; Pressoreceptors - physiology ; Propranolol - pharmacology ; Reflex - drug effects ; Reflex - physiology ; Regional Blood Flow - drug effects ; Stroke Volume - drug effects ; Systole - drug effects</subject><ispartof>Circulation (New York, N.Y.), 1986-05, Vol.73 (5), p.938-950</ispartof><rights>1986 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c468t-fd06e8cfb23c5049cfe341fc83ef886c2607a59a3cd6a8376e6bac2138efa2b23</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8691260$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3698239$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>AVERSANO, T</creatorcontrib><creatorcontrib>MAUGHAN, W. L</creatorcontrib><creatorcontrib>HUNTER, W. C</creatorcontrib><creatorcontrib>KASS, D</creatorcontrib><creatorcontrib>BECKER, L. C</creatorcontrib><title>End-systolic measures of regional ventricular performance</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><description>Dimension change measures of regional ventricular function, such as absolute or percent wall thickening (delta T or % delta T) or segmental shortening (delta L or % delta L), are highly load dependent. In 16 anesthetized mongrel dogs we assessed use of the end-systolic pressure-thickness and end-systolic pressure-length relationships (ESPTR, ESPLR) as more load-independent measures of regional function. We found that the ESPTR and ESPLR could be measured without detectable baroreceptor-mediated reflex changes in cardiac contractile state. Systemic administration of dobutamine shifted the ESPTR to the right and the ESPLR to the left of control, mainly due to a change in the slope (Ees) of the relationships. Both delta T, % delta T and delta L, % delta L failed to detect the positive inotropic effect of dobutamine because of an associated reduction in preload. With systemic administration of propranolol, ESPTR, ESPLR, delta T, % delta T, and delta L, % delta L detected the negative inotropic effect. Thus systemic propranolol shifted the ESPTR to the left and the ESPLR to the right of control, mainly due to a change in Ees. Regional administration of dobutamine shifted the ESPTR and the ESPLR in the direction of positive contractility in the region receiving the drug, whereas simple dimension change measures of regional function failed to detect the inotropic effect because preload fell and the timing of regional end-systole was altered. With regional propranolol both the ESPTR, ESPLR and simple dimension change measures detected the negative inotropic effect. Thus the ESPTR, ESPLR is a reliable measure of regional ventricular function and may be better than simple dimension change measures of regional function, particularly when loading conditions or the timing of regional systole is altered by an intervention.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Blood Pressure - drug effects</subject><subject>Cardiovascular system</subject><subject>Dobutamine - pharmacology</subject><subject>Dogs</subject><subject>Female</subject><subject>Heart - anatomy &amp; histology</subject><subject>Heart - physiology</subject><subject>Hemodynamics - drug effects</subject><subject>Investigative techniques of hemodynamics</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Myocardial Contraction - drug effects</subject><subject>Pressoreceptors - drug effects</subject><subject>Pressoreceptors - physiology</subject><subject>Propranolol - pharmacology</subject><subject>Reflex - drug effects</subject><subject>Reflex - physiology</subject><subject>Regional Blood Flow - drug effects</subject><subject>Stroke Volume - drug effects</subject><subject>Systole - drug effects</subject><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><recordid>eNo9kM1LAzEQxYMotVbPnoQ9iLfdJpndbHKUUrVQEETPIc1OZGU_arIr9L9vpEtPwzC_95j3CLlnNGNMsCVlma19VkJWZArkBZmzgudpXoC6JHNKqUpL4Pya3ITwE1cBZTEjMxBKclBzotZdlYZDGPqmtkmLJoweQ9K7xON33XemSf6wG3xtx8b4ZI_e9b41ncVbcuVME_Bumgvy9bL-XL2l2_fXzep5m9pcyCF1FRUordtxsAXNlXUIOXNWAjopheWClqZQBmwljIRSoNgZyxlIdIZH1YI8nXz3vv8dMQy6rYPFpjEd9mPQpZA0RqERXJ5A6_sQPDq993Vr_EEzqv_L0pTp1eZDl6ALHcuKiofJety1WJ35qZ14f5zuJljTOB9z1-GMSaFYfB-OZpJyqg</recordid><startdate>19860501</startdate><enddate>19860501</enddate><creator>AVERSANO, T</creator><creator>MAUGHAN, W. L</creator><creator>HUNTER, W. C</creator><creator>KASS, D</creator><creator>BECKER, L. C</creator><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19860501</creationdate><title>End-systolic measures of regional ventricular performance</title><author>AVERSANO, T ; MAUGHAN, W. L ; HUNTER, W. C ; KASS, D ; BECKER, L. C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c468t-fd06e8cfb23c5049cfe341fc83ef886c2607a59a3cd6a8376e6bac2138efa2b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Blood Pressure - drug effects</topic><topic>Cardiovascular system</topic><topic>Dobutamine - pharmacology</topic><topic>Dogs</topic><topic>Female</topic><topic>Heart - anatomy &amp; histology</topic><topic>Heart - physiology</topic><topic>Hemodynamics - drug effects</topic><topic>Investigative techniques of hemodynamics</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Myocardial Contraction - drug effects</topic><topic>Pressoreceptors - drug effects</topic><topic>Pressoreceptors - physiology</topic><topic>Propranolol - pharmacology</topic><topic>Reflex - drug effects</topic><topic>Reflex - physiology</topic><topic>Regional Blood Flow - drug effects</topic><topic>Stroke Volume - drug effects</topic><topic>Systole - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>AVERSANO, T</creatorcontrib><creatorcontrib>MAUGHAN, W. L</creatorcontrib><creatorcontrib>HUNTER, W. C</creatorcontrib><creatorcontrib>KASS, D</creatorcontrib><creatorcontrib>BECKER, L. C</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>AVERSANO, T</au><au>MAUGHAN, W. L</au><au>HUNTER, W. C</au><au>KASS, D</au><au>BECKER, L. C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>End-systolic measures of regional ventricular performance</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>1986-05-01</date><risdate>1986</risdate><volume>73</volume><issue>5</issue><spage>938</spage><epage>950</epage><pages>938-950</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><coden>CIRCAZ</coden><abstract>Dimension change measures of regional ventricular function, such as absolute or percent wall thickening (delta T or % delta T) or segmental shortening (delta L or % delta L), are highly load dependent. In 16 anesthetized mongrel dogs we assessed use of the end-systolic pressure-thickness and end-systolic pressure-length relationships (ESPTR, ESPLR) as more load-independent measures of regional function. We found that the ESPTR and ESPLR could be measured without detectable baroreceptor-mediated reflex changes in cardiac contractile state. Systemic administration of dobutamine shifted the ESPTR to the right and the ESPLR to the left of control, mainly due to a change in the slope (Ees) of the relationships. Both delta T, % delta T and delta L, % delta L failed to detect the positive inotropic effect of dobutamine because of an associated reduction in preload. With systemic administration of propranolol, ESPTR, ESPLR, delta T, % delta T, and delta L, % delta L detected the negative inotropic effect. Thus systemic propranolol shifted the ESPTR to the left and the ESPLR to the right of control, mainly due to a change in Ees. Regional administration of dobutamine shifted the ESPTR and the ESPLR in the direction of positive contractility in the region receiving the drug, whereas simple dimension change measures of regional function failed to detect the inotropic effect because preload fell and the timing of regional end-systole was altered. With regional propranolol both the ESPTR, ESPLR and simple dimension change measures detected the negative inotropic effect. Thus the ESPTR, ESPLR is a reliable measure of regional ventricular function and may be better than simple dimension change measures of regional function, particularly when loading conditions or the timing of regional systole is altered by an intervention.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>3698239</pmid><doi>10.1161/01.cir.73.5.938</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-7322
ispartof Circulation (New York, N.Y.), 1986-05, Vol.73 (5), p.938-950
issn 0009-7322
1524-4539
language eng
recordid cdi_proquest_miscellaneous_76802390
source EZB Electronic Journals Library
subjects Animals
Biological and medical sciences
Blood Pressure - drug effects
Cardiovascular system
Dobutamine - pharmacology
Dogs
Female
Heart - anatomy & histology
Heart - physiology
Hemodynamics - drug effects
Investigative techniques of hemodynamics
Investigative techniques, diagnostic techniques (general aspects)
Male
Medical sciences
Myocardial Contraction - drug effects
Pressoreceptors - drug effects
Pressoreceptors - physiology
Propranolol - pharmacology
Reflex - drug effects
Reflex - physiology
Regional Blood Flow - drug effects
Stroke Volume - drug effects
Systole - drug effects
title End-systolic measures of regional ventricular performance
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T19%3A05%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=End-systolic%20measures%20of%20regional%20ventricular%20performance&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=AVERSANO,%20T&rft.date=1986-05-01&rft.volume=73&rft.issue=5&rft.spage=938&rft.epage=950&rft.pages=938-950&rft.issn=0009-7322&rft.eissn=1524-4539&rft.coden=CIRCAZ&rft_id=info:doi/10.1161/01.cir.73.5.938&rft_dat=%3Cproquest_cross%3E76802390%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c468t-fd06e8cfb23c5049cfe341fc83ef886c2607a59a3cd6a8376e6bac2138efa2b23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=76802390&rft_id=info:pmid/3698239&rfr_iscdi=true